ARTES announce expansion of the management board
Langenfeld, Germany; 10th of January 2024
ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Director beginning of the year. He will manage the company in close cooperation with Dr. Michael Piontek, Managing Director and founder of ARTES Biotechnology and with Dr. Melanie Piontek, Business Development Director.
Volker Jenzelewski started his career at Rhein Biotech GmbH in 1993 after graduating in biology. In positions of increasing responsibility in technical management and GMP manufacturing, Mr. Jenzelewski eventually became Director of Process Development and Head of Manufacturing at Dynavax Europe. His final responsibility was the validation of antigen production and the support of regulatory filings for HEPLISAV-B®, the lead product of Dynavax Technologies Corporation. In the years 2010 to 2013, Mr. Jenzelewski was Managing Director of EUFETS GmbH, a CDMO in the field of advanced therapy medicinal products and a BioNTech subsidiary. He advanced the operative integration of EUFETS and the expansion into mRNA manufacturing.
He joined ARTES Biotechnology GmbH in 2014 as Director of Technology, steering the company´s development and technology transfer activities and providing technical review for business decisions.
With the expansion of the management board by Volker Jenzelewski, ARTES Biotechnology strengthens its position as a first-class solution provider and expands its future activities.
ARTES Management Team, from left to right: Volker Jenzelewski (Managing Director), Melanie Piontek (Business Development Director), Michael Piontek (Managing Director)
